Thay đổi giá

#AUPH (Aurinia Pharmaceuticals Inc). Tỷ giá hối đoái và biểu đồ trực tuyến.

Mở tài khoản giao dịch Mở tài khoản demo

#AMGN Trở lại danh sách các công cụ #AZN

Chuyển đổi tiền tệ

7.59 USD
15 Jan 2025 22:59

$-0.03
(-0.4%)

Đóng cửa trước đó

$7.47

Mở cửa

$7.68

Mức cao của ngày

$7.69

Mức thấp của ngày

$7.47

Mức cao 52-tuần

$8.5

Mức thấp 52-tuần

$7.47

Tải về lưu trữ

Tải về lưu trữ

Aurinia Pharmaceuticals Inc. is a Canadian biotech company specializing in the production of drugs against autoimmune diseases.

Aurinia Pharmaceuticals Inc. maintains cooperation with Japanese companies, particularly Otsuka Pharmaceutical Co.

The company’s market cap currently stands at $1.067 billion. Aurinia reported revenues of $45.6 million last year with a net loss of $180.97 million.

The stock is traded on the NASDAQ exchange under the ticker name of AUPH. There is no information about upcoming dividend payments.

The stock is currently trading between $7.4 and $7.7. Over the past year, the share price has fluctuated from $6.29 to $33.97.

When trading this asset, you should pay attention to the following:

Any negative events and news will be detrimental to the company.
The company's earnings strongly depend on the results of new product trials.
It is not recommended to allocate more than 5% of your investment portfolio to this stock.
This is a high-risk stock with fairly large returns of over 30%.